Nanoparticle Drug Delivery Can Reduce the Hepatotoxicity of Therapeutic Cargo.
Sign Up to like & getrecommendations! Published in 2020 at "Small"
DOI: 10.1002/smll.201906360
Abstract: Hepatotoxicity is a key concern in the clinical translation of nanotherapeutics because preclinical studies have consistently shown that nanotherapeutics accumulates extensively in the liver. However, clinical-stage nanotherapeutics have not shown increased hepatotoxicity. Factors that can… read more here.
Keywords: drug delivery; reduce hepatotoxicity; hepatotoxicity; clinical translation ... See more keywords